In the current subanalysis, we examined the effect of febuxostat, a selective XO inhibitor, on serum MDA‐LDL level, one of the oxidative stress markers, in patients having asymptomatic hyperuricemia and carotid arterial plaques. Here, XDH is linked to hyperuricemia.